| |
Rüberg
|
2009 |
680,00€ |
| |
Rüberg
|
2009 |
680,00€ |
| |
Diabetes Market in UAE
RNCOS E-Services Pvt. Ltd.
Diabetes is the world’s most costly epidemic. It is anticipated that, over 10% of the population in countries such as, the US, Malaysia, and Indonesia will be diabetic by 2020 and
|
2011 |
800,00$ |
| |
Brazil Generics Market Forecast to 2012
RNCOS E-Services Pvt. Ltd.
Since the initial launch of policies, Brazil generic drugs market has been experiencing a stupendous growth. The country is the largest generics market in Latin America and is pois
|
2011 |
1.000,00$ |
| |
Asia Pacific Pharma Sector Analysis
RNCOS E-Services Pvt. Ltd.
The Asia Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. Low labor and manufacturing costs have attracted huge investm
|
2011 |
1.200,00$ |
| |
Booming Generics Drug Market in India
RNCOS E-Services Pvt. Ltd.
Generic drugs have become a new area of interest for pharmaceutical manufacturers. After the recession, demand for generic drugs has significantly soared due to the low cost factor
|
2010 |
1.000,00$ |
| |
German Pharma Sector Analysis
RNCOS E-Services Pvt. Ltd.
Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany are focused on research, which has led the country to become one of the m
|
2010 |
600,00$ |
| |
China Animal Vaccine Industry Report, 2009-2010
Beijing RIC Information Consulting Co. Ltd
China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scal
|
2010 |
1.500,00$ |
| |
China Pharmaceutical Industry Statistics, 2000-2009
Beijing RIC Information Consulting Co. Ltd
Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth.
In the first half of 2009, t
|
2010 |
449,00$ |
| |
China Antibiotic Market Report, 2008-2009
Beijing RIC Information Consulting Co. Ltd
From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the world. In 2007, China's sales revenue of antibiot
|
2008 |
2.500,00$ |
| |
Contraceptives: Market Dynamics – Adoption, Switching and Cross Use Trends Among Ob/Gyn’s in the Birth Control Device Market
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report analyzes the adopt
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: An Evaluation of Professional Education Programs Among Global Endometrial Ablation Competitors
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report provides a compari
|
2008 |
1.500,00$ |
| |
Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
The report identifies unmet ne
|
2008 |
4.000,00$ |
| |
Oral Contraception and Hormone Therapy: How is the Performance of Oral Contraceptive Device and Hormone Therapy Manufacturers Perceived by Ob/Gyn Surgeons?
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report investigates Ob/Gy
|
2008 |
2.500,00$ |
| |
Contraceptive Devices: Treatment Characteristics of Obstetrics and Gynecology Surgeons Specializing in Birth Control Procedures
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report segments Ob/Gyn su
|
2008 |
1.500,00$ |
| |
Obstetrics and Gynecology: Brand Loyalty
Valid Results, Inc.
100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ)
|
2008 |
7.500,00$ |
| |
Abnormal Uterine Bleeding: Trends in Procedures for the Treatment of AUB
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report details the number
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: Analysis of the Ob/Gyn Market Dynamics and Future Trends Among Leading Global Endometrial Ablation Systems
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report analyzes Ob/Gyn su
|
2008 |
2.000,00$ |
| |
Oral Contraception and Hormone Therapy: Investigating the Dynamics of Brand Use - An Analysis of Switching, Exclusive Use and Future Trends in Obstetrics/Gynecology
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Discover the details associate
|
2008 |
2.000,00$ |
| |
Obstetrics and Gynecology: A Snapshot of the Ob/Gyn Surgery Marktet
Valid Results, Inc.
100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ)
|
2008 |
7.500,00$ |
| |
Contraceptive Devices: Improving the Efficiency of Training and Education Methods to Better Meet the Needs of Ob/Gyn Surgeons
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report identifies the pre
|
2008 |
1.500,00$ |
| |
Abnormal Uterine Bleeding: An Evaluation of Sales Reps Among Global Endometrial Ablation Competitors.
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report compares Ob/Gyn su
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: How Competing GEA Companies are Positioned in the Minds of Ob/Gyn Surgeons
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
The report measures Ob/Gyn sur
|
2008 |
2.500,00$ |
| |
Oral Contraception and Hormone Therapy: Insights into the Positioning of Pharmaceutical Companies in the Obstetrics and Gynecology Market
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Learn which companies are seen
|
2008 |
1.500,00$ |
| |
Contraceptive Devices: Where Are They Now? Understanding Obstetrics & Gynecology Trends in the Use of Birth Control Devices
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report encapsulates the c
|
2008 |
2.000,00$ |
| |
Obstetrics and Gynecology: The Opportunity Index
Valid Results, Inc.
100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ)
|
2008 |
7.500,00$ |
| |
Contraceptive Devices: Gap Analysis – Opportunities and Threats in the Contraceptive Device Market
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report identifies opportu
|
2008 |
4.000,00$ |
| |
Abnormal Uterine Bleeding: Considerations that Shape Product Preferences in Obstetrics and Gynecology
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Validate your strategies for m
|
2008 |
3.000,00$ |
| |
Oral Contraception and Hormone Therapy: Improving the Efficiency of Training and Education Methods to Meet the Needs of Ob/Gyn Surgeons
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Learn how Ob/Gyn surgeons pref
|
2008 |
1.500,00$ |
| |
The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency
Valid Results, Inc.
Sample: N=100 Ob/Gyns currently practicing in the United States
Countries Covered: United States
Applicability: The information presented in this report has direct applicabil
|
2008 |
25.000,00$ |
| |
Contraceptive Devices: Improving Professional Education Events for Ob/Gyn’s Specializing in Birth Control Procedures
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report compares Ob/Gyn su
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: Applying the 80/20 Rule to AUB Procedures
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report segments the segme
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: Assessing the Strengths of Associations Between GEA Brands and their Manufacturers
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
How strong is the association
|
2008 |
2.000,00$ |
| |
Oral Contraception and Hormone Therapy: Assessing the Strength of Associations Between Brands and Their Manufacturer.
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Uncover the strength of associ
|
2008 |
2.000,00$ |
| |
Obstetrics and Gynecology: Customer Value Drivers
Valid Results, Inc.
100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ)
|
2008 |
7.500,00$ |
| |
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn Surgeons?
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report provides an in-dep
|
2008 |
3.000,00$ |
| |
Abnormal Uterine Bleeding: How do Ob/Gyn Surgeons Who Perform Global Endometrial Ablation Procedures Prefer to be Trained and Educated on New Products, Procedures and Methods?
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Determines Ob/Gyn surgeons' pr
|
2008 |
1.500,00$ |
| |
Oral Contraception and Hormone Therapy: Evaluating the Effectiveness of Sales Reps in Obstetrics and Gynecology
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Gain insight into Ob/Gyn surge
|
2008 |
2.000,00$ |
| |
Oral Contraception and Hormone Therapy: Revealing Opportunities and Threats in Obstetrics and Gynecology Through Gap Analysis
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Discover the opportunities for
|
2008 |
4.000,00$ |
| |
Contraceptive Devices: Improving Birth Control Device Manufacturers, Sales Rep Performance
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
This report compares Ob/Gyn su
|
2008 |
2.000,00$ |
| |
Abnormal Uterine Bleeding: Patient Characteristics and Treatment Modalities Associated with AUB
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
The report provides insight in
|
2008 |
3.000,00$ |
| |
Abnormal Uterine Bleeding: An Identification and Quantification of the Evaluation Criteria Used by Ob/Gyn Surgeons to Evaluate Global Endometrial Ablation Companies
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
An in-depth measurement of the
|
2008 |
3.000,00$ |
| |
Oral Contraception and Hormone Therapy: What Considerations Shape Preferences in Obstetrics and Gynecology?
Valid Results, Inc.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
Validate your strategies for m
|
2008 |
2.500,00$ |
| |
Obstetrics and Gynecology: The Customer Connection
Valid Results, Inc.
100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ)
|
2008 |
7.500,00$ |
| |
China Chemical Pharmaceutical Industry Report, 2007
Beijing RIC Information Consulting Co. Ltd
Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value inc
|
2007 |
499,00$ |
| |
China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007
Beijing RIC Information Consulting Co. Ltd
During the Tenth Five-Year Plan period (2001 to 2005), each indicator of the whole pharmaceutical industry greatly exceeded the scheduled; and the industrial output value, industri
|
2007 |
1.700,00$ |
| |
China OTC Drug Market Report, 2007
Beijing RIC Information Consulting Co. Ltd
By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the s
|
2007 |
369,00$ |
| |
China Medical Sales Channel Report, 2006-2007
Beijing RIC Information Consulting Co. Ltd
In the first three quarters of 2006, the total sales value of top seven medicine merchandises in China amounted to RMB 211.838 billion, up by 8.07% year-on-year, among which, the t
|
2007 |
900,00$ |
| |
China Pharmaceutical Industry Report, 2006-2007
Beijing RIC Information Consulting Co. Ltd
In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.
It is noteworthy
|
2007 |
299,00$ |
| |
China Medical Devices Market Report, 2007
Beijing RIC Information Consulting Co. Ltd
Presently, the global sales revenue of medical device amounted to about USD 250 billion. Developed countries and regions take the majority of market shares, among which America tak
|
2007 |
369,00$ |
| |
